α-Glucosidase inhibitors boost gut immunity by inducing IgA responses in Peyer's patches.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 15 08 2023
accepted: 20 10 2023
medline: 1 12 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

Peyer's patches (PPs) are specialized gut-associated lymphoid tissues that initiate follicular helper T (Tfh)-mediated immunoglobulin A (IgA) response to luminal antigens derived from commensal symbionts, pathobionts, and dietary sources. IgA-producing B cells migrate from PPs to the small intestinal lamina propria and secrete IgA across the epithelium, modulating the ecological balance of the commensal microbiota and neutralizing pathogenic microorganisms. α-glucosidase inhibitors (α-GIs) are antidiabetic drugs that inhibit carbohydrate digestion in the small intestinal epithelium, leading to alterations in the commensal microbiota composition and metabolic activity. The commensal microbiota and IgA responses exhibit bidirectional interactions that modulate intestinal homeostasis and immunity. However, the effect of α-GIs on the intestinal IgA response remains unclear. We investigated whether α-GIs affect IgA responses by administering voglibose and acarbose to mice via drinking water. We analyzed Tfh cells, germinal center (GC) B cells, and IgA-producing B cells in PPs by flow cytometry. We also assessed pathogen-specific IgA responses. We discovered that voglibose and acarbose induced Tfh cells, GCB cells, and IgA-producing B cells in the PPs of the proximal small intestine in mice. This effect was attributed to the modification of the microbiota rather than a shortage of monosaccharides. Furthermore, voglibose enhanced secretory IgA (S-IgA) production against attenuated

Identifiants

pubmed: 38022673
doi: 10.3389/fimmu.2023.1277637
pmc: PMC10646501
doi:

Substances chimiques

Immunoglobulin A 0
Glycoside Hydrolase Inhibitors 0
Acarbose T58MSI464G
voglibose S77P977AG8
Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1277637

Informations de copyright

Copyright © 2023 Hattori-Muroi, Naganawa-Asaoka, Kabumoto, Tsukamoto, Fujisaki, Fujimura, Komiyama, Kinashi, Kato, Sato, Takahashi and Hase.

Déclaration de conflit d'intérêts

The authors declare that this study was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

Références

Nat Microbiol. 2016 Jul 04;1(9):16103
pubmed: 27562257
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
Nucleic Acids Res. 2007;35(21):7188-96
pubmed: 17947321
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1981-6
pubmed: 14766966
Immunity. 2014 Nov 20;41(5):789-801
pubmed: 25464855
Immunity. 2015 Sep 15;43(3):541-53
pubmed: 26320660
Science. 2017 Oct 20;358(6361):
pubmed: 28971969
J Immunol. 2004 Jul 15;173(2):762-9
pubmed: 15240662
mSphere. 2019 Feb 6;4(1):
pubmed: 30728281
BMC Microbiol. 2019 Jun 13;19(1):130
pubmed: 31195972
Cell. 2015 Oct 8;163(2):367-80
pubmed: 26411289
J Nutr. 1997 May;127(5):717-23
pubmed: 9164992
Science. 2004 Mar 12;303(5664):1662-5
pubmed: 15016999
Diabetes Ther. 2017 Apr;8(2):293-307
pubmed: 28130771
J Exp Med. 2018 Aug 6;215(8):2019-2034
pubmed: 30042191
PLoS One. 2015 Apr 15;10(4):e0124599
pubmed: 25874569
Nature. 2021 Jul;595(7868):560-564
pubmed: 34262176
Cell Host Microbe. 2021 Mar 10;29(3):334-346
pubmed: 33705705
Nat Rev Microbiol. 2016 Jan;14(1):20-32
pubmed: 26499895
J Immunol. 2000 May 15;164(10):5184-91
pubmed: 10799877
Annu Rev Immunol. 2022 Apr 26;40:413-442
pubmed: 35113731
Annu Rev Immunol. 2021 Apr 26;39:449-479
pubmed: 33902310
Nature. 2009 Nov 12;462(7270):226-30
pubmed: 19907495
Gut Microbes. 2016 Jul 3;7(4):313-322
pubmed: 27355107
J Clin Diagn Res. 2013 Dec;7(12):3023-7
pubmed: 24551718
Int Immunol. 2020 Apr 12;32(4):243-258
pubmed: 31858119
J Exp Med. 2019 Apr 1;216(4):831-846
pubmed: 30877171
Cell Host Microbe. 2018 Mar 14;23(3):302-311.e3
pubmed: 29478774
Sci Immunol. 2023 May 26;8(83):eade2335
pubmed: 37235682
J Immunol. 1981 Nov;127(5):2039-43
pubmed: 7028869
Annu Rev Immunol. 2020 Apr 26;38:23-48
pubmed: 32340570
Infect Immun. 1999 Apr;67(4):1992-2000
pubmed: 10085047
Nat Commun. 2014 Apr 10;5:3704
pubmed: 24718324
Nat Med. 1998 Nov;4(11):1247-52
pubmed: 9809547
Immunity. 2016 Apr 19;44(4):875-88
pubmed: 27096318
Adv Carbohydr Chem Biochem. 2012;68:59-436
pubmed: 23218124
Infect Immun. 2008 Mar;76(3):927-34
pubmed: 18086815
Cell. 2009 Oct 30;139(3):485-98
pubmed: 19836068

Auteurs

Kisara Hattori-Muroi (K)

Division of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.

Hanako Naganawa-Asaoka (H)

Division of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.

Yuma Kabumoto (Y)

Division of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.

Kei Tsukamoto (K)

Division of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.

Yosuke Fujisaki (Y)

Division of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.

Yumiko Fujimura (Y)

Division of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.

Seiga Komiyama (S)

Division of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.

Yusuke Kinashi (Y)

Division of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.

Miki Kato (M)

Division of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.

Shintaro Sato (S)

Mucosal Vaccine Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Department of Microbiology and Immunology, School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama, Japan.

Daisuke Takahashi (D)

Division of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Division of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.

Koji Hase (K)

Division of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan.
Division of Biochemistry, Department of Pharmaceutical Sciences, Keio University Faculty of Pharmacy, Tokyo, Japan.
The Institute of Fermentation Sciences (IFeS), Faculty of Food and Agricultural Sciences, Fukushima University, Fukushima, Japan.
International Research and Development Center for Mucosal Vaccines, the Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH